ZBHZimmer Biomet

$101.36

$79.5852 weeks$106.87

Price

$101.36+12%1Y

1M+13%1Y+12%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Above average

8/10

Value51

Quality83

Momentum50

Growth54

Strongest Quality, weakest Momentum · ranked vs Healthcare peers. The five questions below judge the company on its own terms.

What they do

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We design, manufacture and market orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (“CMFT”) products; bone cement; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

In the company’s own words · 10-K filed Feb 20, 2026 · SEC EDGAR

P/E (TTM)26.3

Market Cap$17.02B

1Y Return+12%

5Y Return-33%

Business segments

Q1 2026 · $2.09B

The company’s own SEC segment disclosure.

Knees$828.6M40%
SET$562.2M27%
Hips$524.1M25%
Technology And Data Bone Cement And Surgical$171.8M8%

Zimmer Biomet (ZBH) reported revenue of $2.09B in Q1 2026 (quarter ended March 31, 2026), up 9.3% from the same quarter a year earlier. That came with a gross margin of 72% and net income of $238M (11% of revenue). For the full year FY2025, revenue was $8.23B (+7.2% year on year) and net income $705M. Its largest product in 2026-Q1 was Knees at $829M, 40% of the disclosed total, just ahead of SET at 27%.

Raw charts

11 series · TTM

As reported to the SEC, without any scoring.

Medical Devices

Ranks #14 of 35 by Smart Score